Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Pansy Katrin |

Publications

** = Publications listed in SCI/SSCI/Pubmed

2022

Full paper/article (Journal)

** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14): Doi: 10.3390/ijms23147874 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Review

** Krstic, J; Deutsch, A; Fuchs, J; Gauster, M; Gorsek, Sparovec, T; Hiden, U; Krappinger, JC; Moser, G; Pansy, K; Szmyra, M; Gold, D; Feichtinger, J; Huppertz, B (Dis)similarities between the Decidual and Tumor Microenvironment.
Biomedicines. 2022; 10(5): Doi: 10.3390/biomedicines10051065 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Neumeister, P; Schulz, E; Pansy, K; Szmyra, M; Deutsch, AJ Targeting the Microenvironment for Treating Multiple Myeloma.
Int J Mol Sci. 2022; 23(14): 7627 Doi: 10.3390/ijms23147627 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Uhl, B; Prochazka, KT; Fechter, K; Pansy, K; Greinix, HT; Neumeister, P; Deutsch, AJ Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.
World J Gastrointest Oncol. 2022; 14(1): 153-162. Doi: 10.4251/wjgo.v14.i1.153 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.-64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 10-13, 2022; New Orleans, LA. Doi: 10.1182/blood-2022-163034 [Poster]
Web of Science FullText FullText_MUG

** Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946. Doi: 10.1182/blood-2022-166678 [Poster]
Web of Science FullText FullText_MUG

2021

Review

** Krappinger, JC; Bonstingl, L; Pansy, K; Sallinger, K; Wreglesworth, NI; Grinninger, L; Deutsch, A; El-Heliebi, A; Kroneis, T; Mcfarlane, RJ; Sensen, CW; Feichtinger, J Non-coding Natural Antisense Transcripts: Analysis and Application.
J Biotechnol. 2021; 340:75-101 Doi: 10.1016/j.jbiotec.2021.08.005
Web of Science PubMed FullText FullText_MUG

** Pansy, K; Uhl, B; Krstic, J; Szmyra, M; Fechter, K; Santiso, A; Thüminger, L; Greinix, H; Kargl, J; Prochazka, K; Feichtinger, J; Deutsch, AJ Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Int J Mol Sci. 2021; 22(24): Doi: 10.3390/ijms222413311 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Gaksch, L; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C; Neumeister, P; Prochazka, K; Deutsch, A Distinct expression profile of chemokine receptors is associated with the pathogenesis of follicular lymphoma
ONCOL RES TREAT. 2021; 44: 152-152. [Poster]
Web of Science

2019

Full paper/article (Journal)

** Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19): Doi: 10.3390/ijms20194740 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Deutsch, A; Pansy, K; Beham-Schmid, C; Prokesch, A; Feichtinger, J Nr4a1-loss causes an acceleration of Myc-driven lymphomagenesis and an induction of gene of the B7-CD28
BRIT J CANCER. 2019; 121: 8-8.-Cancer Conference of the National-Cancer-Research-Institute (NCRI); NOV 03-05, 2019; Glasgow, SCOTLAND. [Poster]
Web of Science

** Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82. [Poster]
Web of Science

** Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135. [Oral Communication]
Web of Science

2018

Full paper/article (Journal)

** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528 Doi: 10.1038/s41598-018-32972-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Brauchart, T; Bergmann, TC; Pansy, K; Fechter, K; Greinix, H; Neumeister, P; Deutsch, A Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro
ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien. [Poster]
Web of Science

** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83. [Poster]
Web of Science

** Fechter, K; Pansy, K; Hauer, A; Kargl, J; Krogsdam, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment
ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien. [Poster]
Web of Science

** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81. [Poster]
Web of Science

2017

Full paper/article (Journal)

** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386 Doi: 10.1158/0008-5472.CAN-16-2320 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108. [Poster]
Web of Science

** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN. [Oral Communication]
Web of Science

↑ Top of page / Navigation